Located at the heart of the third largest European university hospital center, Marseille Medical Genetics (MMG) boasts a triple mission: decipher the mechanisms involved in genetic diseases, open new diagnostic and therapeutic pathways and improve the quality of life of patients affected by these rare diseases.

From the genetics of rare diseases to developmental biology, from epigenetics to genome dynamics and from bioinformatics to systems biology, the MMG explores all facets of the discipline through a translational approach that focuses on the patient. The teams are particularly interested in four main families of pathologies:

• Central nervous system and neuroendocrine tissues diseases (CNSNET)
• Neuromuscular diseases (NeMus)
• Cardiovascular diseases (DevCard)
• Accelerated ageing and laminopathies (AgiPreC)

Within these four departments, 150 researchers, clinicians, engineers, post docs and students seek to improve our knowledge of these diseases by combining the exploration of patient cohorts and pathophysiological models using state-of-the-art technologies within five platforms.

Closely associated with the Department of Medical Genetics of the Timone Hospital, the MMG is a joint research unit of Inserm and Aix-Marseille University. Led by Dr Frédérique MAGDINIER, the MMG is also one of the founding members of  MaRCHE, the university hospital federation dedicated to rare diseases, which is certified by A*MIDEX University Foundation, AP-HM and the Alliance des Sciences de la Vie et de la Santé.